Bank of Montreal’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-92,060
Closed -$1.33M 4346
2023
Q2
$1.33M Sell
92,060
-77,134
-46% -$1.1M ﹤0.01% 2022
2023
Q1
$2.62M Buy
+169,194
New +$2.82M ﹤0.01% 1556
2022
Q1
Sell
-11,125
Closed -$112K 4323
2021
Q4
$112K Buy
+11,125
New +$209K ﹤0.01% 3100
2021
Q3
Sell
-39,102
Closed -$1.44M 3982
2021
Q2
$1.44M Buy
39,102
+8,956
+30% +$347K ﹤0.01% 2265
2021
Q1
$1.34M Sell
30,146
-15,718
-34% -$732K ﹤0.01% 1993
2020
Q4
$2.46M Buy
45,864
+3,314
+8% +$196K ﹤0.01% 1727
2020
Q3
$2.39M Sell
42,550
-1,606
-4% -$78.7K ﹤0.01% 1591
2020
Q2
$2.42M Buy
44,156
+44,114
+105,033% +$2.36M ﹤0.01% 1547
2020
Q1
$2K Sell
42
-2,650
-98% -$147K ﹤0.01% 3902
2019
Q4
$167K Buy
2,692
+829
+44% +$39.4K ﹤0.01% 3259
2019
Q3
$63K Buy
1,863
+640
+52% +$18.9K ﹤0.01% 3516
2019
Q2
$28K Buy
+1,223
New +$28.6K ﹤0.01% 3989
2019
Q1
Sell
-129
Closed -$3K 4842
2018
Q4
$3K Buy
129
+67
+108% +$1.65K ﹤0.01% 4296
2018
Q3
$2K Buy
62
+7
+13% +$259 ﹤0.01% 4416
2018
Q2
$2K Buy
+55
New +$1.62K ﹤0.01% 4421

Other funds holding DCPH

Bank of Montreal's DCPH Position: Q3 2023 in Review

Bank of Montreal sold out of Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) in Q3 2023, closing a stake of 92,060 shares — an estimated $1.33M sold.

Bank of Montreal first reported a position in DCPH in Q2 2018 and held it in 15 quarters. The position peaked at $2.62M in Q1 2023. 157 funds tracked by Wall St. Rank hold DCPH as of Q3 2023.

  • Bank of Montreal reported no remaining Deciphera Pharmaceuticals, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Bank of Montreal sold 92,060 Deciphera Pharmaceuticals, Inc. Common Stock shares in Q3 2023, an estimated $1.33M.
  • Bank of Montreal first reported a position in Deciphera Pharmaceuticals, Inc. Common Stock in Q2 2018 and held it in 15 quarters.
  • Bank of Montreal's Deciphera Pharmaceuticals, Inc. Common Stock position peaked at $2.62M in Q1 2023.
  • 157 funds tracked by Wall St. Rank held Deciphera Pharmaceuticals, Inc. Common Stock as of Q3 2023.

Based on Bank of Montreal's 13F filing for Q3 2023, filed 1 Nov 2023.